Article Details

Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical ...

Retrieved on: 2025-03-26 17:14:09

Tags for this article:

Click the tags to see associated articles and topics

Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical .... View article details on hiswai:

Excerpt

Brelovitug is an investigational, highly potent, pan-genotypic, fully human immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that targets the ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo